Back to Search
Start Over
Risk factors for paravalvular leak after transcatheter aortic valve replacement
- Source :
- The Journal of Thoracic and Cardiovascular Surgery. 157:1406-1415.e3
- Publication Year :
- 2019
- Publisher :
- Elsevier BV, 2019.
-
Abstract
- Objective To assess risk factors for paravalvular leak (PVL) after transcatheter aortic valve implantation in a large single-center cohort, including measurement of aortic valve calcification using a reproducible method. Methods We retrospectively analyzed preoperative contrast-enhanced multidetector computed tomography scans of patients who underwent transcatheter aortic valve implantation in our center between 2009 and 2016. Calcium volume was calculated for each aortic cusp in the aortic valve, left ventricular outflow tract, and device landing zone. Results Overall, 539 patients were included in the study who had experience with 4 prothesis types (SapienXT [Edwards Lifesciences, Irvine, Calif] [n = 192], Sapien3 [Edwards Lifesciences] [n = 206], CoreValve EvolutR [Medtronic, Minneapolis, Minn] [n = 44], and Acurate [Symetis, Ecublens, Switzerland] [n = 97]). Median calcium volume in the device landing zone was 757 mm3, with no significant differences among the 4 prosthesis groups. None of the patients had severe PVL. The overall incidence of mild-to-moderate PVL was 15.8% (95% confidence interval [CI], 12.8%-19.1%). On multivariate logistic regression, device landing zone calcification (P = .00006; odds ratio for an increase of 100 mm3, 1.08; 95% CI, 1.04-1.13) and use of the CoreValve (P = .0028; odds ratio, 4.1; 95% CI, 1.6-10 with SapienXT as reference) prosthesis were found to be associated with mild or greater PVL. In contrast, degree of oversizing (P = .002; odds ratio, 0.97; 95% CI, 0.95-0.99), and use of Sapien3 (P = .00005; odds ratio, 0.23; 95% CI, 0.11-0.47 with SapienXT as reference) were associated with a lower incidence of mild or greater PVL. Conclusions Aortic calcification volume in the device landing zone is associated with residual PVL after transcatheter aortic valve implantation. When taking calcification into account, the balloon-expandable prosthesis Sapien3 seems to be associated with a lower incidence of PVL.
- Subjects :
- Male
Pulmonary and Respiratory Medicine
Aortic valve
medicine.medical_specialty
Time Factors
Computed Tomography Angiography
medicine.medical_treatment
Aortic Valve Insufficiency
030204 cardiovascular system & hematology
Coronary Angiography
Risk Assessment
Prosthesis
Transcatheter Aortic Valve Replacement
03 medical and health sciences
0302 clinical medicine
Valve replacement
Risk Factors
Internal medicine
Multidetector Computed Tomography
Humans
Medicine
Aged
Retrospective Studies
Aged, 80 and over
business.industry
Calcinosis
Percutaneous coronary intervention
Aortic Valve Stenosis
Odds ratio
medicine.disease
Echocardiography, Doppler, Color
Prothesis
Treatment Outcome
medicine.anatomical_structure
030228 respiratory system
Aortic Valve
Heart Valve Prosthesis
Cardiology
Female
Surgery
Aortic valve calcification
Cardiology and Cardiovascular Medicine
business
Echocardiography, Transesophageal
Calcification
Subjects
Details
- ISSN :
- 00225223
- Volume :
- 157
- Database :
- OpenAIRE
- Journal :
- The Journal of Thoracic and Cardiovascular Surgery
- Accession number :
- edsair.doi.dedup.....e9c77f0d41e341e53203f57de66e421c